{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:02:35Z","timestamp":1760043755551},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071601907"},{"type":"electronic","value":"9781071601914"}],"license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0191-4_9","type":"book-chapter","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T17:03:47Z","timestamp":1576775027000},"page":"141-168","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Perfusion Control for High Cell Density Cultivation and Viral Vaccine Production"],"prefix":"10.1007","author":[{"given":"Alexander","family":"Nikolay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bissinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendal","family":"Gr\u00e4nicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"issue":"9","key":"9_CR1","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1086\/374419","volume":"187","author":"SA Plotkin","year":"2003","unstructured":"Plotkin SA (2003) Vaccines, vaccination, and vaccinology. J Infect Dis 187(9):1349\u20131359. \nhttps:\/\/doi.org\/10.1086\/374419","journal-title":"J Infect Dis"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","volume":"86","author":"FE Andre","year":"2008","unstructured":"Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff T (2008) Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 86:140\u2013146","journal-title":"Bull World Health Organ"},{"issue":"5","key":"9_CR3","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","volume":"100","author":"F Tapia","year":"2016","unstructured":"Tapia F, V\u00e1zquez-Ram\u00edrez D, Genzel Y, Reichl U (2016) Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. ApplMicrobiolBiotechnol 100(5):2121\u20132132. \nhttps:\/\/doi.org\/10.1007\/s00253-015-7267-9","journal-title":"ApplMicrobiolBiotechnol"},{"key":"9_CR4","first-page":"387","volume-title":"Cell culture technology for pharmaceutical and cell-based therapies","author":"DS Kompala","year":"2005","unstructured":"Kompala DS, Ozturk SS (2005) Optimization of high cell density perfusion bioreactors. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies, vol 1. CRC Press, Boca Raton, pp 387\u2013411"},{"issue":"4","key":"9_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/btpr.2421","volume":"33","author":"DJ Karst","year":"2017","unstructured":"Karst DJ, Steinhoff RF, Kopp MRG, Serra E, Soos M, Zenobi R, Morbidelli M (2017) Intracellular CHO cell metabolite profiling reveals steady-state dependent metabolic fingerprints in perfusion culture. BiotechnolProgr 33(4):879\u2013890. \nhttps:\/\/doi.org\/10.1002\/btpr.2421","journal-title":"BiotechnolProgr"},{"issue":"1","key":"9_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/bf00353919","volume":"22","author":"SS Ozturk","year":"1996","unstructured":"Ozturk SS (1996) Engineering challenges in high density cell culture systems. Cytotechnology 22(1):3\u201316. \nhttps:\/\/doi.org\/10.1007\/bf00353919","journal-title":"Cytotechnology"},{"issue":"1","key":"9_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1026192228471","volume":"42","author":"JE Dowd","year":"2003","unstructured":"Dowd JE, Jubb A, Kwok KE, Piret JM (2003) Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates. Cytotechnology 42(1):35\u201345. \nhttps:\/\/doi.org\/10.1023\/A:1026192228471","journal-title":"Cytotechnology"},{"issue":"22","key":"9_CR8","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1016\/j.vaccine.2017.10.112","volume":"36","author":"D Vazquez-Ramirez","year":"2018","unstructured":"Vazquez-Ramirez D, Genzel Y, Jordan I, Sandig V, Reichl U (2018) High-cell-density cultivations to increase MVA virus production. Vaccine 36(22):3124\u20133133. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2017.10.112","journal-title":"Vaccine"},{"issue":"7","key":"9_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/bit.26259","volume":"114","author":"GW Hiller","year":"2017","unstructured":"Hiller GW, Ovalle AM, Gagnon MP, Curran ML, Wang W (2017) Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures. BiotechnolBioeng 114(7):1438\u20131447. \nhttps:\/\/doi.org\/10.1002\/bit.26259","journal-title":"BiotechnolBioeng"},{"issue":"9","key":"9_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","volume":"14","author":"LE Gallo-Ramirez","year":"2015","unstructured":"Gallo-Ramirez LE, Nikolay A, Genzel Y, Reichl U (2015) Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev Vaccines 14(9):1181\u20131195. \nhttps:\/\/doi.org\/10.1586\/14760584.2015.1067144","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"9_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.vaccine.2008.11.066","volume":"27","author":"I Jordan","year":"2009","unstructured":"Jordan I, Vos A, Beilfu\u00df S, Neubert A, Breul S, Sandig V (2009) An avian cell line designed for production of highly attenuated viruses. Vaccine 27(5):748\u2013756. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2008.11.066","journal-title":"Vaccine"},{"issue":"5","key":"9_CR12","first-page":"419","volume":"64","author":"SW Brown","year":"2010","unstructured":"Brown SW, Mehtali M (2010) The Avian EB66(R) cell line, application to vaccines, and therapeutic protein production. PDA JPharmaceutSciTechnol\/ PDA 64(5):419\u2013425","journal-title":"PDA JPharmaceutSciTechnol\/ PDA"},{"issue":"11","key":"9_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141686","volume":"10","author":"D Huang","year":"2015","unstructured":"Huang D, Peng W-J, Ye Q, Liu X-P, Zhao L, Fan L, Xia-Hou K, Jia H-J, Luo J, Zhou L-T, Li B-B, Wang S-L, Xu W-T, Chen Z, Tan W-S (2015) Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines. PLoS One 10(11):e0141686. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0141686","journal-title":"PLoS One"},{"issue":"3","key":"9_CR14","first-page":"227","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman C (1908) The method of \u2018right and wrong cases\u2019(\u2018constant stimuli\u2019) without Gauss\u2019s formulae. Br J Psychol 2(3):227\u2013242","journal-title":"Br J Psychol"},{"issue":"4","key":"9_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/bf01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G (1931) BeitragzurkollektivenBehandlungpharmakologischerReihenversuche. Naunyn-SchmiedebergsArchivf\u00fcrexperimentellePathologie und Pharmakologie 162(4):480\u2013483. \nhttps:\/\/doi.org\/10.1007\/bf01863914","journal-title":"Naunyn-SchmiedebergsArchivf\u00fcrexperimentellePathologie und Pharmakologie"},{"key":"9_CR16","first-page":"75","volume":"101","author":"K Konstantinov","year":"2006","unstructured":"Konstantinov K, Goudar C, Ng M, Meneses R, Thrift J, Chuppa S, Matanguihan C, Michaels J, Naveh D (2006) The\u201cpush-to-low\u201d approach for optimization of high-density perfusion cultures of animal cells. AdvBiochemEng\/Biotechnol 101:75\u201398","journal-title":"AdvBiochemEng\/Biotechnol"},{"issue":"20","key":"9_CR17","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1007\/s00253-018-9275-z","volume":"102","author":"A Nikolay","year":"2018","unstructured":"Nikolay A, L\u00e9on A, Schwamborn K, Genzel Y, Reichl U (2018) Process intensification of EB66\u00ae cell cultivations leads to high-yield yellow fever and Zika virus production. ApplMicrobiolBiotechnol 102(20):8725\u20138737. \nhttps:\/\/doi.org\/10.1007\/s00253-018-9275-z","journal-title":"ApplMicrobiolBiotechnol"},{"issue":"7","key":"9_CR18","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00253-019-09694-2","volume":"103","author":"D V\u00e1zquez-Ram\u00edrez","year":"2019","unstructured":"V\u00e1zquez-Ram\u00edrez D, Jordan I, Sandig V, Genzel Y, Reichl U (2019) High titer MVA and influenza A virus production using a hybrid fed-batch\/perfusion strategy with an ATF system. ApplMicrobiolBiotechnol 103(7):3025\u20133035. \nhttps:\/\/doi.org\/10.1007\/s00253-019-09694-2","journal-title":"ApplMicrobiolBiotechnol"},{"issue":"24","key":"9_CR19","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","volume":"32","author":"Y Genzel","year":"2014","unstructured":"Genzel Y, Vogel T, Buck J, Behrendt I, Ramirez DV, Schiedner G, Jordan I, Reichl U (2014) High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine 32(24):2770\u20132781. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2014.02.016","journal-title":"Vaccine"},{"issue":"3","key":"9_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jbiotec.2005.03.009","volume":"119","author":"TB Ferreira","year":"2005","unstructured":"Ferreira TB, Ferreira AL, Carrondo MJT, Alves PM (2005) Effect of refeed strategies and non-ammoniagenic medium on adenovirus production at high cell densities. J Biotechnol 119(3):272\u2013280. \nhttps:\/\/doi.org\/10.1016\/j.jbiotec.2005.03.009","journal-title":"J Biotechnol"}],"container-title":["Methods in Molecular Biology","Animal Cell Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0191-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T17:24:27Z","timestamp":1576776267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0191-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"ISBN":["9781071601907","9781071601914"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0191-4_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"20 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}